116 related articles for article (PubMed ID: 16103416)
1. Evaluation of division-arrested cells for cell-based high-throughput screening and profiling.
Digan ME; Pou C; Niu H; Zhang JH
J Biomol Screen; 2005 Sep; 10(6):615-23. PubMed ID: 16103416
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of cell lines for high-throughput screening of human neuromedin U receptor subtype 2 specific agonists using a luciferase reporter gene assay.
Li X; Shen F; Zhang Y; Zhu J; Huang L; Shi Q
Eur J Pharm Biopharm; 2007 Aug; 67(1):284-92. PubMed ID: 17337170
[TBL] [Abstract][Full Text] [Related]
3. A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors.
Lin WH; Song JS; Chang TY; Chang CY; Fu YN; Yeh CL; Wu SH; Huang YW; Fang MY; Lien TW; Hsieh HP; Chao YS; Huang SF; Tsai SF; Wang LM; Hsu JT; Chen YR
Anal Biochem; 2008 Jun; 377(1):89-94. PubMed ID: 18358823
[TBL] [Abstract][Full Text] [Related]
4. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
5. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
Gardner DP; Shimizu N
J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
[TBL] [Abstract][Full Text] [Related]
6. Label-free and real-time cell-based kinase assay for screening selective and potent receptor tyrosine kinase inhibitors using microelectronic sensor array.
Atienza JM; Yu N; Wang X; Xu X; Abassi Y
J Biomol Screen; 2006 Sep; 11(6):634-43. PubMed ID: 16858006
[TBL] [Abstract][Full Text] [Related]
7. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.
Ahmad N; Gali H; Javed S; Agarwal R
Biochem Biophys Res Commun; 1998 Jun; 247(2):294-301. PubMed ID: 9642119
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
9. Importance of tyrosine phosphatases in the effects of cell-cell contact and microenvironments on EGF-stimulated tyrosine phosphorylation.
Mansbridge JN; Knüchel R; Knapp AM; Sutherland RM
J Cell Physiol; 1992 Jun; 151(3):433-42. PubMed ID: 1284249
[TBL] [Abstract][Full Text] [Related]
10. Development of a quantitative, high-throughput cell-based enzyme-linked immunosorbent assay for detection of colony-stimulating factor-1 receptor tyrosine kinase inhibitors.
Baumann CA; Zeng L; Donatelli RR; Maroney AC
J Biochem Biophys Methods; 2004 Jul; 60(1):69-79. PubMed ID: 15236912
[TBL] [Abstract][Full Text] [Related]
11. Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells.
Krystal GW; Honsawek S; Kiewlich D; Liang C; Vasile S; Sun L; McMahon G; Lipson KE
Cancer Res; 2001 May; 61(9):3660-8. PubMed ID: 11325836
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of protein tyrosine phosphorylation: preliminary assessment of activity by time-resolved fluorescence.
Amir-Zaltsman Y; Mazor O; Gayer B; Scherz A; Salomon Y; Kohen F
Luminescence; 2000; 15(6):377-80. PubMed ID: 11114114
[TBL] [Abstract][Full Text] [Related]
13. A reporter gene assay for high-throughput screening of G-protein-coupled receptors stably or transiently expressed in HEK293 EBNA cells grown in suspension culture.
Durocher Y; Perret S; Thibaudeau E; Gaumond MH; Kamen A; Stocco R; Abramovitz M
Anal Biochem; 2000 Sep; 284(2):316-26. PubMed ID: 10964415
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
Feldkamp MM; Lau N; Guha A
Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
[TBL] [Abstract][Full Text] [Related]
15. Further comparison of primary hit identification by different assay technologies and effects of assay measurement variability.
Wu X; Sills MA; Zhang JH
J Biomol Screen; 2005 Sep; 10(6):581-9. PubMed ID: 16103421
[TBL] [Abstract][Full Text] [Related]
16. Multiplexing nuclear receptors for agonist identification in a cell-based reporter gene high-throughput screen.
Grover GS; Turner BA; Parker CN; Meier J; Lala DS; Lee PH
J Biomol Screen; 2003 Jun; 8(3):239-46. PubMed ID: 12857377
[TBL] [Abstract][Full Text] [Related]
17. Adopting a practical statistical approach for evaluating assay agreement in drug discovery.
Sun D; Whitty A; Papadatos J; Newman M; Donnelly J; Bowes S; Josiah S
J Biomol Screen; 2005 Aug; 10(5):508-16. PubMed ID: 16093560
[TBL] [Abstract][Full Text] [Related]
18. Discovery and characterization of a novel inhibitor of CDC25B, LGH00045.
Feng X; Wang LN; Zhou YY; Yu HP; Shen Q; Zang Y; Zhou YB; Li JY; Zhang HX; Li J
Acta Pharmacol Sin; 2008 Oct; 29(10):1268-74. PubMed ID: 18817634
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of phospholipase Cgamma1 activity during EGF-induced proliferation of corneal epithelial cells: effect of phosphoinositide-3 kinase.
Islam M; Akhtar RA
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1472-8. PubMed ID: 11381049
[TBL] [Abstract][Full Text] [Related]
20. Application of division arrest technology to cell-based HTS: comparison with frozen and fresh cells.
Kunapuli P; Zheng W; Weber M; Solly K; Mull R; Platchek M; Cong M; Zhong Z; Strulovici B
Assay Drug Dev Technol; 2005 Feb; 3(1):17-26. PubMed ID: 15798392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
